(Q34621771)

3 August 2017

1 reference

title

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward (English)

1 reference

3 August 2017

1 reference

3

Donald Shepard

1 reference

3 August 2017

Daniel Wolfe

1

1 reference

PubMed ID

20650513

3 August 2017

M Patrizia Carrieri

series ordinal

2

1 reference

PubMed ID

20650513

3 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

3 August 2017

1 reference

3 August 2017

376

1 reference

3 August 2017

355-366

1 reference

3 August 2017

9738

1 reference

Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

A review of barriers and facilitators of HIV treatment among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Five-year outcomes of the China National Free Antiretroviral Treatment Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Rates of inappropriate antiretroviral prescription among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Nonstructured treatment interruptions among injection drug users in Baltimore, MD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Determinants of HAART discontinuation among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Self-Reported Adherence to Antiretroviral Treatment among HIV-Infected People in Central China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Case management of human immunodeficiency virus-infected injection drug users: a case study in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Modified Directly Observed Therapy (MDOT) for Injection Drug Users with HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Directly observed therapy for the management of HIV-infected patients in a methadone program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Incentives vs outreach workers for latent tuberculosis treatment in drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Women and substance use in India and Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Drug injection cessation among HIV-infected injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

HIV and risk environment for injecting drug users: the past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Improving the data to strengthen the global response to HIV among people who inject drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Social costs of robbery and the cost-effectiveness of substance abuse treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Value for money in drug treatment: economic evaluation of prison methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

The social structural production of HIV risk among injecting drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

The ‘risk environment’: a framework for understanding and reducing drug-related harm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Attitudes, knowledge, and perceptions of Chinese doctors toward drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

On drug treatment and social control: Russian narcology's great leap backwards

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

New challenges and opportunities in managing substance abuse in Malaysia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

In rehabilitation's name? Ending institutionalised cruelty and degrading treatment of people who use drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Impact of HIV prevention programs on drug users in Malaysia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Half a gram – a thousand lives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Preventing death among the recently incarcerated: an argument for naloxone prescription before release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Social and structural aspects of the overdose risk environment in St. Petersburg, Russia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Nonfatal Overdose Among Heroin Users in Southwestern China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among out-of-treatment injecting drug users in North Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Vladimir Mendelevich: fighting for drug substitution treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Survey of abuses against injecting drug users in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

The Global Fund's leadership on harm reduction: 2002-2009.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Call for action to secure universal access to ART in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Social and structural determinants of HAART access and adherence among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960832-X

7 January 2021

10.1016/S0140-6736(10)60832-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

20650513